Researchers at the University of California, Irvine, have developed a groundbreaking therapy for Alzheimer’s disease by using stem cells to program human immune cells for targeted treatment.

After decades of setbacks, Alzheimer’s drug development is expanding beyond anti-amyloids, with a record number of trials and ...

The exact numbers depended on the type of medication patients took, but the risk of developing Alzheimer’s was up to 70 ...

Four South Florida sites are enrolling people with memory loss into a national trial for benfotiamine, a lab-made vitamin that could slow down progression of Alzheimer’s.

Researchers at the Lawson Health Research Institute, part of St. Joseph’s Health Care London, are studying Ambroxol, a cough ...

A new study from the University of California San Diego has uncovered a hidden cause of Alzheimer’s disease that may lead to ...

A survey of older Americans found that 79% would want to know if they were in the early stages of Alzheimer's, and 92% said that if diagnosed, they would probably or definitely want to take a drug ...

Breast cancer survivors treated with radiation therapy have an 8% lower risk of developing Alzheimer’s disease, albeit only ...

A new drug originally developed to treat a different brain disease is now showing signs that it could help people with ...

Memantine, the only drug approved for the treatment of Alzheimer's disease, has recently been made available in an extended-release formulation. What do you need to know about this new product?

A compound derived from rosemary, known as carnosic acid, has been transformed into a potent brain-boosting drug that combats Alzheimer’s by reducing inflammation and stress in the brain — all ...

We know that a complex combination of factors contribute to Alzheimer's disease risk, including genetics, mental health, and ...